Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 201

Similar articles for PubMed (Select 9225876)

1.

Double-blind, placebo-controlled cross-over study of intravenous S-adenosyl-L-methionine in patients with fibromyalgia.

Volkmann H, Nørregaard J, Jacobsen S, Danneskiold-Samsøe B, Knoke G, Nehrdich D.

Scand J Rheumatol. 1997;26(3):206-11.

PMID:
9225876
2.

Effects of low power laser and low dose amitriptyline therapy on clinical symptoms and quality of life in fibromyalgia: a single-blind, placebo-controlled trial.

Gür A, Karakoc M, Nas K, Cevik R, Sarac J, Ataoglu S.

Rheumatol Int. 2002 Sep;22(5):188-93. Epub 2002 Jul 6.

PMID:
12215864
3.

Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

Jacobsen S, Danneskiold-Samsøe B, Andersen RB.

Scand J Rheumatol. 1991;20(4):294-302.

PMID:
1925418
4.

Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.

Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y.

Clin Ther. 2008 Nov;30(11):1988-2004. doi: 10.1016/j.clinthera.2008.11.009. Erratum in: Clin Ther. 2009 Feb;31(2):446. Clin Ther. 2009 Jul;31(7):1617.

PMID:
19108787
5.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

7.

Fibromyalgia treatment with intravenous tropisetron administration.

Stratz T, Färber L, Varga B, Baumgartner C, Haus U, Müller W.

Drugs Exp Clin Res. 2001;27(3):113-8.

PMID:
11447769
8.

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.

Branco JC, Zachrisson O, Perrot S, Mainguy Y; Multinational Coordinator Study Group.

J Rheumatol. 2010 Apr;37(4):851-9. doi: 10.3899/jrheum.090884. Epub 2010 Feb 15.

PMID:
20156949
9.

Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Distler O, Eich W, Dokoupilova E, Dvorak Z, Fleck M, Gaubitz M, Hechler M, Jansen JP, Krause A, Bendszus M, Pache L, Reiter R, Müller-Ladner U.

Arthritis Rheum. 2010 Jan;62(1):291-300. doi: 10.1002/art.25062.

10.

Double-blind, multicenter trial comparing acetyl l-carnitine with placebo in the treatment of fibromyalgia patients.

Rossini M, Di Munno O, Valentini G, Bianchi G, Biasi G, Cacace E, Malesci D, La Montagna G, Viapiana O, Adami S.

Clin Exp Rheumatol. 2007 Mar-Apr;25(2):182-8.

PMID:
17543140
11.

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia.

Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr.

Am J Med. 2002 Feb 15;112(3):191-7.

PMID:
11893345
12.

The effects of sodium oxybate on clinical symptoms and sleep patterns in patients with fibromyalgia.

Scharf MB, Baumann M, Berkowitz DV.

J Rheumatol. 2003 May;30(5):1070-4.

PMID:
12734908
13.

No effect of antiviral (valacyclovir) treatment in fibromyalgia: a double blind, randomized study.

Kendall SA, Schaadt ML, Graff LB, Wittrup I, Malmskov H, Krogsgaard K, Bartels EM, Bliddal H, Danneskiold-Samsøe B.

J Rheumatol. 2004 Apr;31(4):783-4.

PMID:
15088307
14.

Relationships between the fibromyalgia impact questionnaire, tender point count, and muscle strength in female patients with fibromyalgia: a cohort study.

Henriksen M, Lund H, Christensen R, Jespersen A, Dreyer L, Bennett RM, Danneskiold-Samsøe B, Bliddal H.

Arthritis Rheum. 2009 Jun 15;61(6):732-9. doi: 10.1002/art.24512.

15.

Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect.

Salaffi F, Sarzi-Puttini P, Girolimetti R, Gasparini S, Atzeni F, Grassi W.

Arthritis Res Ther. 2009;11(4):R125. doi: 10.1186/ar2792. Epub 2009 Aug 18.

16.

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.

Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, Wernicke JF.

Pain. 2005 Dec 15;119(1-3):5-15. Epub 2005 Nov 17.

PMID:
16298061
17.

The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study.

Moldofsky H, Lue FA, Mously C, Roth-Schechter B, Reynolds WJ.

J Rheumatol. 1996 Mar;23(3):529-33.

PMID:
8832997
18.

Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design.

Bell IR, Lewis DA 2nd, Brooks AJ, Schwartz GE, Lewis SE, Caspi O, Cunningham V, Baldwin CM.

J Altern Complement Med. 2004 Apr;10(2):269-83.

PMID:
15165408
19.

Efficacy of Raloxifen in treatment of fibromyalgia in menopausal women.

Sadreddini S, Molaeefard M, Noshad H, Ardalan M, Asadi A.

Eur J Intern Med. 2008 Jul;19(5):350-5. doi: 10.1016/j.ejim.2007.10.006. Epub 2007 Nov 28.

PMID:
18549938
20.

Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo.

Bell IR, Lewis DA 2nd, Brooks AJ, Schwartz GE, Lewis SE, Walsh BT, Baldwin CM.

Rheumatology (Oxford). 2004 May;43(5):577-82. Epub 2004 Jan 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk